Hypoxia induced EPO-R is mediated by HIF1α through sequential interaction with EGR1 and SP1; thus, the hypoxia/HIF1α/EGR1/SP1/EPO-R axis may be potential targets for NSCLC diagnosis and therapy. This evidence concerns the gene HIF1A and non-small cell lung carcinoma.